Premacio, Reynaldo .
HRN: 26-76-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
CEFTRIAXONE 1G (VIAL)
03/04/2025
03/04/2025
IV
2g
Now
Nephrolithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes